Danichi Yoshida
Physician Assistant · Newport Beach, CANPI 1679971352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 661 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,198, 2.5 times the $1,656 reported in 2021. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 661 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Johnson & Johnson$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- plus $7K from 26 others
What the payments were for
- Travel & lodging$380%
- Food & beverage$15,72599%
- Education$630%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 59 | $1,875 |
| Neurocrine Biosciences, Inc. | 57 | $1,526 |
| Johnson & Johnson | 52 | $1,476 |
| Otsuka America Pharmaceutical, Inc. | 50 | $1,461 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $1,375 |
| AbbVie | 51 | $1,073 |
| Teva Pharmaceuticals USA, Inc. | 59 | $1,059 |
| Sunovion Pharmaceuticals Inc. | 35 | $891 |
| Lundbeck LLC | 46 | $874 |
| Alkermes, Inc. | 44 | $816 |
| Axsome Therapeutics, Inc. | 33 | $806 |
| Bausch Health US, LLC | 30 | $525 |
| Corium, LLC | 14 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $276 |
| E.r. Squibb & Sons, L.L.C. | 6 | $234 |
| Ironshore Pharmaceuticals Inc. | 8 | $187 |
| Noven Therapeutics, LLC | 8 | $146 |
| Indivior Inc. | 6 | $140 |
| Gilead | 1 | $120 |
| Biogen | 5 | $105 |
| Vertical Pharmaceuticals, LLC | 5 | $102 |
| Braeburn Inc. | 4 | $88 |
| Janssen Scientific Affairs, LLC | 1 | $83 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| Adlon Therapeutics L.p. | 4 | $67 |
| Eisai Inc. | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Almatica Pharma LLC | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $20 |
| Noven Pharmaceuticals, Inc. | 1 | $16 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,826 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 24 | $11,118 |
| Lurasidone Hcl | 46 | $8,189 |
| Aripiprazole | 38 | $6,685 |
| Clozapine | 25 | $2,610 |
| Bupropion XlBupropion Hcl | 95 | $2,179 |
| Vilazodone Hcl | 11 | $1,653 |
| Duloxetine Hcl | 48 | $1,561 |
| Olanzapine | 55 | $1,352 |
| Paroxetine ErParoxetine Hcl | 13 | $1,228 |
| Trazodone Hcl | 77 | $1,190 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $1,131 |
| Mirtazapine | 78 | $981 |
| Sertraline Hcl | 85 | $896 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 27 | $876 |
| Fluvoxamine Maleate | 11 | $858 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $26 | $89685 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Newport Beach
- Sally de Castro TilsenNewport Beach$77K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.